J. McGowan

发表

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

Susan R. Johnson, R. Krauss, R. Langer, 1995 .

Age, gender, and race/ethnic differences in total body and subregional bone density

L. Melton, T. Harris, J. Shepherd, 2009, Osteoporosis International.

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

S. Cummings, C. Lewis, J. Cauley, 2005, Contemporary clinical trials.

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

JoAnn E. Manson, Emily White, S. Heckbert, 1998, Controlled clinical trials.

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

M. Bouxsein, L. Palermo, K. Ensrud, 2004 .

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

S. Silverman, D. Felsenberg, J. Cauley, 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

CHAPTER 72 – Estrogen Therapy: Prevention and Treatment of Osteoporosis

M. Stefanick, J. McGowan, 2008 .

Risk factors for low bone mass in healthy 40–60 year old women: A systematic review of the literature

J. McGowan, G. Hawker, S. Jamal, 2008, Osteoporosis International.

Perspectives on the future of bone and joint diseases.

J. McGowan, 2003, The Journal of rheumatology. Supplement.

The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants.

A. LaCroix, J. Cauley, R. Jackson, 2003, Annals of epidemiology.

Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational Study

A. LaCroix, C. Lewis, J. Hsia, 2003, Annals of Internal Medicine.

Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women’s Health Initiative

J. Manson, A. LaCroix, C. Kooperberg, 2018, Circulation. Heart failure.

Osteoporosis: Assessment of bone loss and remodeling

J. McGowan, 1993, Aging.

Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.

S. Majumdar, M. Bouxsein, L. Palermo, 2008, The Journal of clinical endocrinology and metabolism.

Commentary on the Women's Health Initiative.

L. Pottern, J. McGowan, 2000, Maturitas.

Calcium plus vitamin D supplementation and the risk of fractures.

J. Manson, A. LaCroix, S. Cummings, 2006, The New England journal of medicine.

Calcium plus vitamin D supplementation and the risk of fractures: Commentary

J. Manson, A. LaCroix, S. Cummings, 2006 .

Does statin use reduce risk of fracture in postmenopausal women? Results from the womens health initiative observational study

A. LaCroix, C. Lewis, J. Hsia, 2000 .

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Mary L Bouxsein, M. Bouxsein, L. Palermo, 2003, The New England journal of medicine.

Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

S. Silverman, D. Felsenberg, J. Cauley, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

National Institutes of Health Research Plan on Rehabilitation

J. Fleg, C. Wiggs, P. Khalsa, 2017, Physical therapy.

Risk factors for low BMD in healthy men age 50 years or older: a systematic review

Jacques P. Brown, J. McGowan, G. Hawker, 2009, Osteoporosis International.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

A. LaCroix, S. Cummings, C. Lewis, 2003, JAMA.

Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits.

Claude Bouchard, Mary Evans, Lyndon Joseph, 2015, Cell metabolism.

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Susan R. Johnson, R. Langer, E. Barrett-Connor, 1996, JAMA.

Both Light Intensity and Moderate‐to‐Vigorous Physical Activity Measured by Accelerometry Are Favorably Associated With Cardiometabolic Risk Factors in Older Women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study

J. Manson, A. LaCroix, C. Kooperberg, 2017, Journal of the American Heart Association.

Rare loss of function variants in candidate genes and risk of colorectal cancer

Taylor J. Maxwell, Jennifer G. Robinson, Andrew J. Sanford, 2018, Human Genetics.

Factors Associated With New‐Onset Depression Following Ischemic Stroke: The Women's Health Initiative

J. Manson, A. LaCroix, C. Kooperberg, 2017, Journal of the American Heart Association.

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.

L. Palermo, K. Ensrud, D. Black, 2005, The New England journal of medicine.

The evolution of the Women's Health Initiative: perspectives from the NIH.

V. Pinn, J. Rossouw, L. Finnegan, 1995, Journal of the American Medical Women's Association.

Coronary Artery Calcification (CAC) and Post‐Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen‐Alone Trial

Jennifer G. Robinson, J. Manson, A. LaCroix, 2017, Journal of the American Heart Association.

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

John P. Bilezikian, L. Palermo, K. Ensrud, 2006 .

Change in Physical Activity and Sitting Time After Myocardial Infarction and Mortality Among Postmenopausal Women in the Women's Health Initiative‐Observational Study

Andrea K. Chomistek, J. Manson, A. LaCroix, 2017, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits.

M. Rodgers, W. Kraus, J. Fleg, 2015, Cell metabolism.

Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

T. Bush, V. Barnabei, R. Schenken, 1996 .